Jane Street Group, LLC Ensysce Biosciences, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.05 - $153.6 $1,021 - $3.14 Million	20,431 New	20,431 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.05 - $153.6 $1,021 - $3.14 Million	20,431 New	20,431 $4,000
Q1 2022 May 17, 2022	SELL	$230.4 - $1140.0 $3.86 Million - $19.1 Million	-16,733 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$300.0 - $1228.8 $1.25 Million - $5.14 Million	4,180 Added 33.3%	16,733 $79,000
Q3 2021 Nov 16, 2021	BUY	$696.0 - $3477.6 $8.74 Million - $43.7 Million	12,553 New	12,553 $38,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $979K
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.